Who are the women blazing trails in biopharma R&D? Nominate them for Endpoints' 2022 special report
Over the past three years, Endpoints News has spotlighted 60 women who have blazed trails and supercharged R&D across the biopharma world. And judging from the response we’ve received, to both our special reports and live events, telling their stories — including any obstacles they may have had to overcome — has inspired our readers in many different ways.
But change takes time, and the fact remains that women are still underrepresented at the upper ranks of the drug-making world.
We are continuing with our annual tradition of putting together a special report to recognize the growing number of enterprising women who are making waves in biopharma R&D.
They may all have different views on issues and tackle gender diversity differently. They may also come from diverse geographic or ethnic backgrounds. But they are increasingly speaking up: After Roe v. Wade was overturned earlier this year, women across the industry have led the fight for increased access to reproductive care.
Women and those in minority groups make up just 14% of board members at public micro- and small-cap companies, according to a recent report by the Bedford Group and Transearch. And when it comes to board chairs, they represent just 5.7% and 4.3%, respectively.
Our lists are never meant to be exhaustive. Rather, we hope they will serve as a collection of snapshots in time, portraits that will both honor and commemorate the contributions these women have made to the creation of new medicines.
So tell us about your CEOs, CMOs, CSOs, R&D directors and the like who have left an impression at your workplace, or at any other firm within the industry. Their formal roles matter less than the impact they’ve brought.
You may fill in the nomination form here or below. Alternatively, you can email your nominations to us at email@example.com and firstname.lastname@example.org. Nominations close on Aug. 29, and our special report will run later this year.
We look forward to meeting all of them.